Month: January 2024

Moximed
Global, United States

Moximed Announces Appointment of Dave Amerson to Board of Directors

Amerson has demonstrated commercial leadership of multiple early-stage medical device technologies with nearly $3 billion in transaction value for investors FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that Dave Amerson has joined the company’s Board of Directors. “I am thrilled to join Moximed’s Board of Directors at this … Continue reading Moximed Announces Appointment of Dave Amerson to Board of Directors

Impact Newswire
AdvanCell
Australia, Global

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY–(BUSINESS WIRE)–AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of Anna Karmann, MD, PhD as the company’s Chief Medical Officer based in San Francisco. “Anna’s passion, insights, entrepreneurial mindset and expertise are invaluable to AdvanCell as we develop our portfolio of Targeted Alpha Therapies for patients globally.”Post this Dr. Karmann joins from RayzeBio, … Continue reading AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

Impact Newswire
Mission Bio
Global, United States

Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life sciences industry, he brings a unique combination of scientific innovation … Continue reading Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Impact Newswire
HYAS
Global

Cybersecurity Visionary Kate Kuehn Joins HYAS Board of Directors

Respected Cybersecurity Veteran Endorses the Usage of Adversary Infrastructure Expertise to Drive Proactive Threat Intelligence and Next-Generation Protective DNS for Operational Resiliency VANCOUVER, British Columbia–(BUSINESS WIRE)–HYAS Infosec, an adversary infrastructure platform provider that offers unparalleled visibility, protection, and security against all kinds of malware and attacks, today announced that industry leader Kate Kuehn has joined the company as a Board Director.HYAS is industry-changing threat prevention, … Continue reading Cybersecurity Visionary Kate Kuehn Joins HYAS Board of Directors

Impact Newswire
BARCLAYS
Global, Untied Kingdom

Barclays appoints Ryan Voegeli as Head of Investment Banking for Canada

With 20 years of Investment Banking experience, Mr. Voegeli brings to Barclays deep client relationships and industry knowledge that will further strengthen the existing Canada platform, and extensively complement the broader Americas and Global Corporate and Investment Banking businesses NEW YORK–(BUSINESS WIRE)–Barclays today announces the appointment of Ryan Voegeli as Head of Investment Banking for Canada. Mr. Voegeli will be based in Toronto. “Under Ryan’s … Continue reading Barclays appoints Ryan Voegeli as Head of Investment Banking for Canada

Impact Newswire